Weight/Heart/Hormonal
Forskolin
Herbal extract from Coleus forskohlii that may modestly reduce body fat and blood pressure in overweight adults, but evidence is limited.
Forskolin
Herbal extract from Coleus forskohlii that may modestly reduce body fat and blood pressure in overweight adults, but evidence is limited.
40
C
evidenceCaution
riskProven Benefits
01May reduce body fat
02May lower blood pressure
03May improve fasting glucose
04May improve lipid profile
05May support free testosterone
Chemical Forms
Recommended
- Coleus forskohlii root extract standardized to 10% forskolin
- Coleus forskohlii root extract standardized to 20% forskolin
- Standardized forskolin extract (label-stated % and mg per serving)
Avoid
- Raw Coleus forskohlii root powder (low active content, unstandardized)
- Proprietary blends hiding forskolin dose
Expert Note
Standardized root extracts match the material used in human trials and give a predictable forskolin dose. Raw root powder varies widely and often contains too little active compound to reproduce published effects.
Protocol
Amount
250 mg of 10% extract
Frequency
Twice daily
When
30 minutes before meals.
Condition-Based Dosing
General weight-management support
250 mg of 10% extract twice daily (25 mg forskolin per dose; 50 mg/day)
Overweight men in a supervised fat-loss trial
500 mg of 10% extract twice daily (50 mg forskolin per dose; 100 mg/day)
Safety & Limits
Upper Safe Limit
1,000 mg/day of 10% extract (highest short-term RCT dose; no official UL)
Cycling
8-12 weeks on, then stop or reassess; no long-term safety data beyond 12 weeks
Contraindications
Hypotension or antihypertensive therapy — risk of excessive blood pressure drop
Bleeding disorders or anticoagulant therapy — theoretical increased bleeding risk
Pregnancy or breastfeeding — insufficient safety data
Surgery — discontinue 2 weeks before due to bleeding risk
Avoid Combining With
- ✕Antihypertensive medications (additive BP lowering — monitor closely)
- ✕Caffeine or pre-workouts (may worsen palpitations and dizziness)
- ✕Anticoagulants and antiplatelet drugs (theoretical bleeding risk)
Updated Invalid Date